Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria flag Bulgaria · Delayed Price · Currency is BGN
17.13
+0.57 (3.47%)
At close: Jul 7, 2025

BUL:THQM Revenue

Tchaikapharma High Quality Medicines AD had revenue of 16.19M BGN in the quarter ending March 31, 2025, with 21.16% growth. This brings the company's revenue in the last twelve months to 55.97M, up 15.96% year-over-year. In the year 2024, Tchaikapharma High Quality Medicines AD had annual revenue of 53.14M with 9.54% growth.

Revenue (ttm)
55.97M
Revenue Growth
+15.96%
P/S Ratio
29.36
Revenue / Employee
256.73K
Employees
207
Market Cap
1.64B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 53.14M 4.63M 9.54%
Dec 31, 2023 48.51M 5.37M 12.44%
Dec 31, 2022 43.15M 715.00K 1.69%
Dec 31, 2021 42.43M 2.33M 5.80%
Dec 31, 2020 40.11M 5.38M 15.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Shelly Group SE 220.30M
Speedy AD 525.58M
First Investment Bank AD 456.76M
Eurohold Bulgaria AD 3.03B
Sopharma AD 2.27B
M+S Hydraulic AD 142.25M
Smart Organic AD 99.16M
Holding Varna AD 88.88M
Revenue Rankings